BACKGROUND AND PARTIES. 1.1 Calgene II, Inc. ("NEWCO") is a Delaware corporation, having a principal place of business at 0000 Xxxxx Xxxxxx, Xxxxx, Xxxxxxxxxx 00000.
1.2 Monsanto Company ("MONSANTO") is a Delaware corporation, having a principal place of business at 000 Xxxxx Xxxxxxxxx Xxxxxxxxx, Xx. Xxxxx, Xxxxxxxx 00000.
1.3 NEWCO and MONSANTO are mutually interested in entering into a transaction involving the licensing of certain patent and know-how rights subject to the terms and conditions of this AGREEMENT.
BACKGROUND AND PARTIES. 1.01 Calgene, Inc., ("Calgene") is a Delaware corporation, having a principal place of business at 0000 Xxxxx Xxxxxx, Xxxxx, Xxxxxxxxxx 00000.
BACKGROUND AND PARTIES. 1.01 Monsanto Company ("MONSANTO") is a corporation of the State of Delaware with principal offices at 800 X. Xxxxxxxxx Xxxxxxxxx, St. Louis, Missouri 63167.
1.02 DEKALB Genetics Corporation ("DEKALB") is a corporation of the State of Delaware with principal offices at 3100 Xxxxxxxx Xxxx, XxXxxx, Xxxxxxxx 00000.
1.03 MONSANTO has certain rights relating to Genetic Element(s), Germplasm, Plasmid(s) and Gene(s), including technical information and Know-How relating to, among other things, transformed plants and seeds, useful for Glyphosate protection in corn plants and has rights in and to patents and/or patent applications covering the Genetic Element(s), Germplasm, Plasmid(s) and Gene(s) and their use.
1.04 DEKALB has certain rights relating to Genetic Element(s), Germplasm, Plasmid(s) and Gene(s), including technical information and Know-How relating to, among other things, transformed plants and seeds, useful for Glyphosate protection in corn plants and has rights in and to patents and/or patent applications covering the Genetic Element(s), Germplasm, Plasmid(s) and Gene(s) and their use.
BACKGROUND AND PARTIES. Stena Recycling A/S ("Stena") is a company with extensive expertise in the recycling and waste industry. Stena is certified according to ISO 14001 and ISO 45001. Stena’s destruction and data confidentiality services are marketed under the brand name REISSWOLF (Reisswolf). Xxxxxxxxx performs the services on which the orderer ("Customer") and Xxxxxxxxx have agreed, in accordance with the terms and conditions in this Agreement.
BACKGROUND AND PARTIES. 1.01 Monsanto Company ("MONSANTO") is a corporation of the State of Delaware with principal offices at 800 X. Xxxxxxxxx Xxxxxxxxx, St. Louis, Missouri 63167.
1.02 DEKALB Genetics Corporation ("DEKALB") is a corporation of the State of Delaware with principal offices at 3100 Xxxxxxxx Xxxx, XxXxxx, Xxxxxxxx 00000.
1.03 MONSANTO has certain rights in and to patents and/or patent applications covering Gene(s) and their use.
1.04 DEKALB possesses patents and patent applications, knowledge, know-how, technical information, germplasm and expertise regarding the development and marketing of corn hybrids.
1.05 DEKALB is interested in the commercialization of certain herbicide-protected seed corn and DEKALB seeks to obtain a limited license under MONSANTO's proprietary rights.
1.06 MONSANTO desires to grant such license, all upon the terms and conditions provided herein.
BACKGROUND AND PARTIES. The parties to this Settlement Agreement (“Agreement”) are the United States of America and the City of Ansonia, Connecticut. The City of Ansonia is a “public entity” within the meaning of the Americans with Disabilities Act of 1990 (“ADA”), 42 U.S.C. § 12131(1), and is, therefore, subject to title II of the ADA, 42 U.S.C. § 12131 et seq., and its implementing regulations, 28 C.F.R. Part 35. This matter was initiated by a complaint filed with the United States Department of Justice (“DOJ”) pursuant to title II of the ADA. The complainant, Recovery Network of Programs, who planned to open a treatment facility for qualified individuals with substance abuse disabilities, was not permitted to open the facility by the City of Ansonia because the City’s zoning code excluded substance abuse treatment facilities from certain zones. The complainant alleges that the City refused to allow the facility on the basis of disability, in violation of the ADA. Under title II of the ADA, no qualified individual with a disability shall, by reason of such disability, be excluded from participation in or denied the benefits of the services, programs, or activities of a public entity, such as the City of Ansonia, or be subjected to discrimination by any such entity. 42 U.S.C. § 12132; 28 C.F.R. § 35.130. Zoning and land use decisions are services, programs, or activities of a public entity. The Department of Justice is the federal agency responsible for administering and enforcing title II of the ADA with respect to all programs, services, and regulatory activities relating to planning and development by public entities, 28 C.F.R. § 35.190. The Attorney General is authorized to bring a civil action enforcing title II of the ADA if the Department of Justice is unable to secure compliance by voluntary means. 42 U.S.C. § 12133; 28 C.F.R. Part 35, Subpart F. The United States of America and the City of Ansonia have agreed to resolve this matter as set forth below. This agreement shall not be construed as an admission of liability or wrongdoing by the City of Ansonia.
BACKGROUND AND PARTIES. 1.01 Monsanto Company ("MONSANTO") is a corporation of the State of Delaware with principal offices at 800 X. Xxxxxxxxx Xxxxxxxxx, St. Louis, Missouri 63167.
1.02 DEKALB Genetics Corporation ("DEKALB") is a corporation of the State of Delaware with principal offices at 3100 Xxxxxxxx Xxxx, XxXxxx, Xxxxxxxx 00000.
1.03 MONSANTO has certain rights relating to genetic element(s), germplasm, plasmid(s), and gene(s), including knowledge, know-how, technical information, and expertise, relating to and useful in agricultural biotechnology and plant genetics directed to the development of plants having desirable characteristics, such as but not limited to resistance to disease, damage by pests, and damage by chemical agents, and to other crop improvements, such as but not limited to increased crop yield and increased concentration in the crop of a desired component, and has rights in and to patents and/or patent applications covering the genetic element(s), germplasm, plasmid(s), and gene(s) and other aspects of agricultural biotechnology and plant genetics.
1.04 DEKALB has certain rights relating to genetic element(s), germplasm, plasmid(s), and gene(s), including knowledge, know-how, technical information, and expertise, relating to and useful in agricultural biotechnology and plant genetics directed to the development of plants having desirable characteristics, such as but not limited to resistance to disease, damage by pests, and damage by chemical agents, and to other crop improvements, such as but not limited to increased crop yield and increased concentration in the crop of a desired component, and has rights in and to patents and/or patent applications covering the genetic element(s), germplasm, plasmid(s), and gene(s) and other aspects of agricultural biotechnology and plant genetics.
1.05 The parties are interested in the development and commercialization of plants having such characteristics. Each party therefore is interested in obtaining a limited license under the other party's property rights, and desires to grant such a license to the other, all upon the terms and conditions provided herein.
1.06 The parties agree that significant mutual benefits may be realized by making available to each other and to third parties such improvements in agricultural 2 biotechnology and plant genetics as may result from such research and development and other activities. The parties agree to make such improvements available to each other and to third parties in accor...
BACKGROUND AND PARTIES. The parties to this Settlement Agreement (the “Agreement”) are the United States of America and Concentra Health Services, Inc., for itself, and on behalf of its managed professional medical entities situated throughout the United States (hereinafter “Concentra” and together with the United States, the “Parties”).
BACKGROUND AND PARTIES. A. The parties to this Settlement Agreement are Plaintiff Xxxxxx Xxx, Plaintiff-Intervenor the United States of America, and Defendants Trinity Health Systems and Trinity Regional Medical Center. Trinity Health Systems is a private, non-profit organization that operates a health care system consisting, inter alia, of hospitals and other health services, including the Trinity Regional Medical Center, located at 000 Xxxxxx Xxxx, Fort Dodge, Iowa. The closest metropolitan area to the Hospital is approximately two hours away by car.
B. On March 3, 2011, Plaintiff filed this lawsuit against Defendants, alleging, among other things, that they failed to provide her with sign language interpreters and otherwise failed to effectively communicate with her in violation of title III of the Americans with Disabilities Act of 1990 (“ADA”), 42 U.S.C. §§ 12181-12189, and Section 504 of the Rehabilitation Act of 1973 (“Xxxxxxx 000”), 00 X.X.X. § 000. Plaintiff sought, among other things, monetary damages, injunctive relief, and attorneys’ fees.
C. After Plaintiff filed her lawsuit, the United States Department of Justice (the “Department”) opened an investigation into the allegations made by Plaintiff in order to determine whether Defendants violated title III of the ADA.
D. The Department is authorized to investigate alleged violations of title III of the ADA, and to bring a civil action in federal court if the Attorney General has reasonable cause to believe that any person or group of persons is engaged in a pattern or practice of discrimination or any person or group of persons has been discriminated against and such discrimination raises an issue of general public importance, 42 U.S.C. § 12188(b)(1)(B).
E. After completing its investigation, the United States filed a complaint in intervention in this lawsuit against Trinity Regional Medical Center and Trinity Health Systems claiming that Defendants violated title III of the ADA, 42 U.S.C. §§ 12181-12189, and its implementing regulation, 28 C.F.R. §§ 36.101-36.608, by failing to provide appropriate auxiliary aids and services, including qualified sign language interpreters, when such aids and services were necessary to ensure effective communication with deaf individuals at Trinity Regional Medical Center. The complaint-in-intervention also alleges that Defendants discriminated against friends and family of deaf patients by forcing them to serve as sign language interpreters when they were neither qualified nor willing...
BACKGROUND AND PARTIES. The parties to this Settlement Agreement ("Agreement") are the United States of America and the Town of Gretna, Virginia. The Town of Gretna is a "public entity" within the meaning of the Americans with Disabilities Act of 1990 ("ADA"), 42 U.S.C. § 12131(1), and is, therefore, subject to title II of the ADA, 42 U.S.C. § 12131 et seq., and its implementing regulations, 28 C.F.R. Part 35. This matter was initiated by a complaint filed with the United States Department of Justice pursuant to title II of the ADA. The complainant, who planned to fxxxxx adults with developmental disabilities in her home, was told by the Town of Gretna that a Special Use Permit was required. The complainant alleges that the Town denied the permit on the basis of disability, in violation of the ADA. Under title II of the ADA, no qualified individual with a disability shall, by reason of such disability, be excluded from participation in or denied the benefits of the services, programs, or activities of a public entity, such as the Town of Gretna, or be subjected to discrimination by any such entity. 42 U.S.C. § 12132, 28 C.F.R. § 35.130. Title II´s prohibitions include association discrimination, so that a public entity shall not exclude or otherwise deny equal services, programs, or activities to an individual or entity because of the known disability of an individual with whom the individual or entity is known to have a relationship or association. 28 C.F.R. § 35.130(g). The Department of Justice is the federal agency responsible for administering and enforcing title II of the ADA with respect to all programs, services, and regulatory activities relating to planning and development by public entities, 28 C.F.R. § 35.190. The Attorney General is authorized to bring a civil action enforcing title II of the ADA if the Department of Justice is unable to secure compliance by voluntary means. 42 U.S.C. § 12133; 28 C.F.R. Part 35, Subpart F. The parties have agreed to resolve this matter as set forth below. This Agreement shall not be construed as an admission of liability or wrongdoing by the Town of Gretna.